Kymera Therapeutics, Inc. ( KYMR) - Key Metrics
KYMR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.03 | -$1.03 | -$0.79 | -$0.79 |
| 2025Q3 | $0.03 | -$0.94 | -$0.31 | -$0.31 |
| 2025Q2 | $0.14 | -$0.95 | -$0.74 | -$0.75 |
| 2025Q1 | $0.28 | -$0.82 | -$0.99 | -$0.99 |
KYMR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -18.86 |
| 2025Q3 | ? | -15.03 |
| 2025Q2 | ? | -11.46 |
| 2025Q1 | ? | -8.36 |
KYMR
Price: $110.57
52 week price:
Earnings Per Share: -3.58 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 492600
Market Capitalization: 9.8 billion